CClinicalTrials.gg
CompletedNCT01654341MID-FrailUpdated Mar 26, 2019

Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes

An interventional study of Exercise, dietary and educational program in Type 2 Diabetes Mellitus, sponsored by Hospital Universitario Getafe. Completed at 1 site in Spain. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2019-03-26.

Sponsored by Hospital Universitario Getafe · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
986
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

The MID-Frail STUDY project focuses on the use of interventions designed to improve functional status and enhance quality of life (rather than traditional treatments such as glucose- and blood pressure- lowering) by acting on the mechanisms involved in producing frailty and its progression to adverse outcomes.

Read the detailed description

Detailed Description: Subjects enrolled in the main study will also be invited to join the following sub-studies:

GENEFRAIL: this sub-study aims to determine the polymorphisms of several genes associated to frailty, in order to establish its predictive value for developing disability and response to treatment as well METABOFRAIL: this sub-study aims to investigate the metabolomic profile of frail and pre-frail patients. SARTRAIN: the combination of the assessment tools used in SARTRAIN (ARFI US, MRI, posturographic measurements) will provide a comprehensive study of the structural and functional characteristics of muscle and adjacent tissues and their change with time and the intervention. MID- POW: this sub-study aims to investigate changes in muscle power.

The project also include an randomized controlled ancillary study: SENSOLE for which the aim is to investigate the potential effects of vibrating insoles device on gait and posture.

02

Conditions studied

  • Type 2 Diabetes Mellitus
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 986 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Hospital Universitario Getafe is the lead sponsor of 28 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participant is willing and able to give written informed consent for participation in the study.
  • Subjects aged 70 years or older, with a diagnosis of type 2 diabetes mellitus for at least 2 years.
  • Require to fulfill Fried ́s criteria for frail or pre-frail individuals.

Exclusion criteria

Exclusion criteria:

  • Barthel score lower than 60 points.
  • Inability to carry out SPPB test (total score=0).
  • Mini Mental State Examination score less than 20 points.
  • Subjects unwilling or unable to consent or unable to participate safely in intervention program.
  • Previous history of myocardial infarction within 6 months, unstable angina or congestive heart failure in III-IV NYHA stage.
  • Clinically instable patients in the clinical judgment of the investigator.
  • Terminal illness (life expectancy \< 6 months).
  • Any other condition that, in the clinical judgment of the investigator, means that it would not in the patient's best interests to enter the study.
  • Current participation in clinical trial or any other investigational study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
986 participants (actual)

Study arms

  • No intervention
    Usual Care Group

    Subjects undergo usual standard of care

  • Experimental
    Intervention Group

    Intervention with exercise, dietary and educational programs

    Behavioral: Exercise, dietary and educational program

Interventions

  • BehavioralExercise, dietary and educational program
06

What researchers measure

Primary outcomes

  1. Changes in summary ordinal score on the Short Physical Performance Battery test

    The Short Physical Performance Battery (SPPB) is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines 3 areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. These areas represent essential tasks important for independent living and are thus an important outcome measure for patients with cardiovascular and pulmonary disease.

    Time frame: 2 years

Secondary outcomes

  1. Lawton Instrumental Activity of Daily Living (IADL) scale

    Time frame: 2 years

  2. Barthel index of activities of daily living

    Time frame: 2 years

  3. Euro-Quality of Life (QoL) index

    Time frame: 2 years

  4. Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life,

    Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life, using an economic model embracing the direct health-related costs (in-patient, out-patient, pharmaceutical, etc), formal care costs (home care, respite care, day centers, etc) and the informal care costs (carer).

    Time frame: 2 years

  5. Symptomatic hypoglycaemia

    Episodes of symptomatic hypoglycaemia (i.e., a recorded blood sugar less than 4 mmol/L, or symptoms or signs attributed to low blood sugar and responding to appropriate treatment)

    Time frame: 2 years

  6. Hospital admissions

    Episodes of hospital admission (i.e., any admission involving an overnight stay)

    Time frame: 2 years

  7. Episodes of permanent institutionalization

    Episodes of permanent institutionalization (i.e., permanent move to any care setting other than the patient's own home, where paid staff are available to provide care if needed at any time during the day or night).

    Time frame: 2 years

  8. Caregiver Strain Index

    Burden of the carer, as assessed by the modified Caregiver Strain Index

    Time frame: 2 years

  9. Mortality

    Time frame: 2 years

07

Study locations

1 site
  • Hospital Universitario de Getafe
    Madrid, Getafe 28905, Spain
08

References and documents

Publications

  • Regueme SC, Cowtan C, Sedgelmaci MY, Kelson M, Poustis J, Rodriguez-Manas L, Sinclair AJ, Dallaudiere B, Bourdel-Marchasson I. A Therapeutic Insole Device for Postural Stability in Older People With Type 2 Diabetes. A Feasibility Study (SENSOLE Part I). Front Med (Lausanne). 2019 Jun 27;6:127. doi: 10.3389/fmed.2019.00127. eCollection 2019. PubMed 31316984 ↗
  • Rodriguez-Manas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ, Moreira S, Cook J; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34. doi: 10.1186/1745-6215-15-34. PubMed 24456998 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01654341
Lead sponsor
Hospital Universitario Getafe
Collaborators
Cardiff University, Igen Biotech SL, University Hospital, Bordeaux, Hexabio Sarl, University of Campania Luigi Vanvitelli, University Hospital, Toulouse, University of Ulm, University Ghent, University of Castilla-La Mancha, Univerzita Karlova v Praze, Niche Science & Technology Ltd, Catholic University of the Sacred Heart, Vrije Universiteit Brussel, Diabetes Frail Ltd
Responsible party
Sponsor
First posted
Jul 31, 2012
Start date
Dec 2013
Primary completion
Feb 2017
Completion
Feb 2017
Last update
Mar 26, 2019

Study contacts

Leocadio Rodríguez Mañas, MD
principal investigator · Hospital Universitario de Getafe

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion